DGITH Group

Drug eluting balloons (DEBs) have emerged as one of the most impactful technologies in vascular treatment. They combine mechanical dilation with localized drug delivery, reducing the risk of restenosis while preserving vessel integrity. Unlike stents, which remain implanted, DEBs leave no permanent metal structure behind. This “leave-nothing-behind” philosophy allows for natural vessel movement, reduces inflammatory reaction, and provides long-term flexibility in future interventions.

DEBs are coated with drugs such as paclitaxel or sirolimus—agents known for preventing excessive tissue growth inside blood vessels. When the balloon inflates, the drug is transferred directly onto the vessel wall in a controlled, homogeneous manner. This targeted approach reduces the likelihood of scar tissue formation, one of the main causes of artery re-narrowing after conventional angioplasty.

A major benefit of DEBs is their versatility. They are used in peripheral artery disease, coronary artery disease, hemodialysis access maintenance, and even in some emerging non-vascular applications. Because…

Oncolytic virotherapy represents one of the most innovative directions in modern oncology, offering a treatment approach that is fundamentally different from chemotherapy, radiation, or surgery. Instead of relying on drugs that target rapidly dividing cells or invasive techniques to remove tumors, oncolytic virotherapy uses specially modified viruses to infect and destroy cancer cells. These viruses are engineered to replicate only inside malignant cells, causing them to burst while leaving healthy tissues largely unharmed. This selective ability makes oncolytic viruses a powerful tool in the search for safer, more precise cancer interventions.

Another significant benefit of this treatment lies in the immune response it triggers. When cancer cells are destroyed by viral replication, they release antigens that alert the immune system to the presence of disease. This process helps the body recognize cancer more effectively, sometimes enhancing the results achieved by immunotherapies. In this way, oncolytic virotherapy does not act only…

Heparin has long been a cornerstone drug in hospitals, especially in emergency and surgical settings where preventing blood clots is essential. Derived originally from animal tissues, this anticoagulant continues to be one of the most trusted options for clinicians. Its value lies in its ability to act quickly within the bloodstream, interrupting clot formation and reducing the chance of life-threatening complications such as pulmonary embolism or deep vein thrombosis. While newer anticoagulants have entered the medical field, Heparin remains unmatched for rapid, controlled action, especially in acute care environments.

One of the defining strengths of Heparin is its adaptability. It can be administered intravenously for immediate effect or subcutaneously for more stable, longer-lasting anticoagulation. Intensive care units rely on it when managing patients on dialysis, ventilation, or those recovering from major surgeries. Even in cardiac procedures, Heparin is indispensable for keeping vessels and devices free from clots. Its predictable behavior,…

Compounded pharmacy services have become a cornerstone of personalized healthcare, offering tailored medications that meet the specific needs of patients who cannot be adequately served by commercially available drugs. These pharmacies specialize in preparing customized formulations, adjusting dose, strength, flavor, delivery method, or ingredients to address individual sensitivities or medical requirements. For many patients, especially those with unique health limitations, compounding opens access to medications that would otherwise be difficult to obtain or tolerate.

One of the most common applications of compounding lies in modifying medications to suit children, elderly individuals, or patients with allergies. Pediatric patients, for example, often struggle with tablets or bitter-tasting medicines, so pharmacists may create flavored liquid versions to improve compliance. Similarly, individuals allergic to dyes or preservatives can receive medications free of those additives. Compounding is not limited to human medicine; veterinarians also rely on customized medications to accommodate different animal species and behaviors.